Orbital irradiation for thyroid orbitopathy: 4 years experience

Authors

  • Chan-chung Liang Hong Kong Eye Hospital, Kowloon, Hong Kong, China.
  • Sin-ming Chow Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
  • Kam-tong Yuen Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
  • Chun-key Law Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.

Abstract

Objective: To review the practice of orbital irradiation in thyroid orbitopathy.

Methods: Review of the records of patients who received orbital irradiation for thyroid orbitopathy between June 1995 and June 1999. Twenty four patients were treated with a radiotherapy protocol. The practice of radiotherapy was analyzed and various clinical parameters were mea- sured to document the response during follow up.

Results: Radiotherapy was used as first-line treatment for 7 patients (29%) and as second-line treatment for 9 (38%), while 8 patients (33%) had combined therapy with steroids. Soft tissue signs and compressive optic neuropathy showed the most favorable outcome while ocular motility and proptosis had a less positive outcome. No ocular complications were detected during follow-up.

Conclusion: Orbital irradiation is a safe and effective way of treating active thyroid orbitopathy.

Downloads

Published

2001-12-01

How to Cite

1.
Liang C- chung, Chow S- ming, Yuen K- tong, Law C- key. Orbital irradiation for thyroid orbitopathy: 4 years experience. Hong Kong J Ophthalmol [Internet]. 2001Dec.1 [cited 2021Oct.27];5(1):8-12. Available from: https://hkjo.hk/index.php/hkjo/article/view/118

Issue

Section

Original Articles